Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LK4X
|
|||
| Former ID |
DCL000738
|
|||
| Drug Name |
Carebastine
|
|||
| Synonyms |
Carebastina; Carebastinum; Carebastina [Spanish]; Carebastine [INN]; Carebastinum [Latin]; E00013; P-(4-(4-(Diphenylmethoxy)piperidino)butyryl)-alpha-methylhydratropic acid; 2-(4-(4-(4-Benzhydryloxypiperidino)butyryl)phenyl)-2-methylpropionsaeure; 2-[4-[4-(4-benzhydryloxypiperidin-1-yl)butanoyl]phenyl]-2-methylpropanoic acid
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Ocular allergy [ICD-11: 4A81] | Phase 3 | [1] | |
| Company |
Almirall Prodesfarma
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C32H37NO4
|
|||
| Canonical SMILES |
CC(C)(C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4)C(=O)O
|
|||
| InChI |
1S/C32H37NO4/c1-32(2,31(35)36)27-17-15-24(16-18-27)29(34)14-9-21-33-22-19-28(20-23-33)37-30(25-10-5-3-6-11-25)26-12-7-4-8-13-26/h3-8,10-13,15-18,28,30H,9,14,19-23H2,1-2H3,(H,35,36)
|
|||
| InChIKey |
XGHOVGYJHWQGCC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 90729-42-3
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
8189959, 14933281, 43122562, 50065373, 57315754, 76260521, 96021045, 96099827, 99004171, 103266610, 104179142, 104334739, 129684714, 134339231, 135025191, 142347591, 162257944, 163133382, 163414205, 163849080, 164837836, 172871484, 179151417, 184819506, 198947536, 223558138, 224702662, 226408527, 252347033, 252487442
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H1 receptor (H1R) | Target Info | Antagonist | [1] |
| KEGG Pathway | Calcium signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| Inflammatory mediator regulation of TRP channels | ||||
| Panther Pathway | Histamine H1 receptor mediated signaling pathway | |||
| Reactome | Histamine receptors | |||
| G alpha (q) signalling events | ||||
| WikiPathways | Monoamine GPCRs | |||
| GPCRs, Class A Rhodopsin-like | ||||
| IL-4 Signaling Pathway | ||||
| Gastrin-CREB signalling pathway via PKC and MAPK | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.